Business
Covalon Secures First Distribution Agreement in China
Medical device distributor to market Covalon's antimicrobial coated catheters throughout Chi...

About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n\n\n\n\n\nMedical device distributor to market Covalon's antimicrobial coated\n catheters throughout China and Hong Kong.\n\n\nTen-year license and distribution agreement includes contractual minimum\n purchase commitments of $7.7 million\n\n\nMISSISSAUGA, ON, Sept. 6, 2011 /CNW/ - Covalon Technologies Ltd. (the\n \"Company\" or \"Covalon\") (TSXV: COV), an advanced medical technologies\n company, today announced a distribution agreement with a China-based\n medical device distributor to market Covalon's antimicrobial coated\n catheters throughout China and Hong Kong.\n\n\nThe ten-year license and distribution agreement includes contractual\n minimum purchase commitments of approximately $7.7 million which\n Covalon will receive over the term of the agreement commencing on\n regulatory approval in China.\n\n\nCovalon's proprietary antimicrobial coating for catheters is designed to\n be effective against the most common and serious pathogens involved in\n the spread of hospital-acquired infections.\n\n\n\"I am extremely pleased that our sales efforts to expand into markets\n beyond the United States are succeeding in creating new opportunities\n for Covalon,\" stated Brian Pedlar, Covalon CEO.  \"Having a partner with\n solid distribution channels in China opens up significant potential to\n introduce leading edge medical devices to the largest patient\n population in the world. We are looking forward to obtaining regulatory\n clearance in China for our advanced coating technology.\"\n\n\nSince 2008, Covalon has supplied FDA-cleared, antimicrobial coated\n catheters to the United States market under private label. These\n Covalon coated catheters are marketed by one of the largest medical\n product distributors in North America.\n\n\nAbout Covalon \n\n\nCovalon Technologies Ltd. researches, develops and commercializes new\n healthcare technologies that help save lives around the world.\n Covalon's patented technologies, products and services address the\n advanced healthcare needs of medical device companies, healthcare\n providers and individual consumers. Covalon's technologies are used to\n prevent, detect and manage medical conditions in specialty areas such\n as wound care, tissue repair, infection control, disease management,\n medical device coatings and biocompatibility. To learn more about\n Covalon, visit our web...